Skip to main content
  • Home
  • About
  • Faculty Experts
  • For The Media
  • Videos
  • Topics
    • Alumni
    • Events
    • Faculty
    • Library
    • Research
    • Students
    • All Topics
  • Contact
  • Submit
STEM
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
Sections
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
  • Home
  • About
  • Faculty Experts
  • For The Media
  • Videos
  • Topics
    • Alumni
    • Events
    • Faculty
    • Library
    • Research
    • Students
    • All Topics
  • Contact
  • Submit
STEM

Cellular Protein Provides Insight to Malaria Treatment’s Side Effects

Tuesday, February 9, 2016, By Elizabeth Droge-Young
Share
College of Arts and Sciencesresearch

Malaria is a worldwide menace. According to the Centers for Disease Control and Prevention, over 500,000 individuals died from malaria in 2013 alone. While treatments for the disease exist, cures can also take a hefty physical toll. Professor of chemistry Robert Doyle in the College of Arts and Sciences, graduate students Brian Huta and Yan Nie, and an international team have begun to unravel the biochemical action of one such malarial drug.

Saposin B, a protein found in the cell's lysosome bound to the anti-malarial drug Chloroquine

Saposin B, a protein found in the cell’s lysosome bound to the anti-malarial drug Chloroquine

The drug chloroquine has long been used to treat malaria, but it is not without side effects. Chloroquine kills malaria by causing the pH in certain parts of the parasite’s cell to increase, preventing important biochemical reactions. Unfortunately, excessive use of the drug can be toxic to humans too. Long-term use of chloroquine can lead to side effects from gastrointestinal distress all the way up to chemical harm to the heart and death.

To better understand how chloroquine toxicity occurs, Doyle and his team set out to investigate what the drug binds to in human cells. Doyle had a hunch that chloroquine might be acting with a particular protein, saposin B, found in the lysosome of cells. Lysosomes break down and remove waste from cells, including excess lipids. People without saposin B develop a fatal, incurable condition, illustrating the importance of this protein in the cell.

“I was studying saposin B interaction with a natural lipid found in cells. It occurred to me that the lysosome is where the anti-malarial drug chloroquine also localizes after you ingest it. Since saposin B can remove damaged lipids, I wondered if it might bind chloroquine and reduce the drug’s toxicity as a consequence,” Doyle says.

The team was pleasantly surprised to find that saposin B does bind chloroquine. This result was unexpected because saposin B is known to bind lipids—and chloroquine is not a lipid. “This is a new class of molecule for saposin B to bind,” Doyle says.

Doyle, Huta and Nie confirmed the binding activity with collaborators at SUNY Potsdam. In addition, collaborators in France determined the physical structures involved in binding. “The fact that we obtained a structure of the saposin B with chloroquine bound was also wonderful, since up until now there has been no structure of saposin B with any bound molecule,” Doyle says. “Quite a first, and a testament to the skills of our collaborators in France.”

This new knowledge of chloroquine binding offers a suggestion as to the drug’s toxicity. Because saposin B binds both lipids and the drug, prolonged use of the drug may keep saposin B busy binding chloroquine instead of removing damaged lipids from the cell, Doyle says.

Now that the team knows that saposin B binds more than just lipids, the door is wide open to investigate other conditions in which the protein may play a role. “The results suggest that saposin B might be up to a lot more than originally thought. We think that it might have a role in play in certain lysosomal storage diseases and have started a new collaboration to explore this approach,” Doyle says.

The study, lead authored by Huta, was featured on the cover of the journal ChemMedChem. The full article can be found here.

  • Author

Elizabeth Droge-Young

  • Recent
  • Syracuse University/SUNY-ESF Team Wins ‘JUMP into STEM’ Competition
    Tuesday, March 2, 2021, By Julie Sharkey
  • US Army Awards Meritorious Civilian Service Medal to Professor Mark Glauser
    Tuesday, March 2, 2021, By Alex Dunbar
  • ‘Is Election Disinformation Free Speech or Defamation? Courts Will Decide’
    Tuesday, March 2, 2021, By Lily Datz
  • University to Guarantee Admission to Eligible Area High School Graduates After Completing Initial Enlistment in US Military
    Tuesday, March 2, 2021, By Brandon Dyer
  • Q&A With Keith Henderson, the University’s New Chief Compliance Officer
    Monday, March 1, 2021, By News Staff

More In STEM

Syracuse University/SUNY-ESF Team Wins ‘JUMP into STEM’ Competition

A team of graduate students representing Syracuse University and the SUNY College of Environmental Science and Forestry (SUNY-ESF) has been named a winner in this year’s “JUMP into STEM” competition, an online building science program sponsored by the U.S. Department…

US Army Awards Meritorious Civilian Service Medal to Professor Mark Glauser

Mark Glauser, professor of mechanical and aerospace engineering in the College of Engineering and Computer Science, has been awarded a Meritorious Civilian Service Medal by the U.S. Army for his work with the Army Science Board. The board provides independent…

Honeywell and Syracuse University Establish Research Partnership to Develop Next-Generation Air Quality Technology

Honeywell and Syracuse University have established a research partnership to fund research on emerging indoor air quality technologies. The partnership will include the naming of a Honeywell Indoor Air Quality Laboratory at the College of Engineering and Computer Science, which…

Aerospace Engineering Alumni Profile: George Kirby ’92

Great technology requires an equally impressive business plan supporting it. The goal is to have a company led by someone who understands what makes the company innovative and also the business and analytical skill to grow it into an industry…

Keeping SARS2 Out of the Cell

As vaccines are distributed worldwide to fight the pandemic, important research at Syracuse University may uncover ways to block it and similar viruses in the future. Alison Patteson, assistant professor of physics, and Jennifer Schwarz, associate professor of physics, recently…

Subscribe to SU Today

If you need help with your subscription, contact sunews@syr.edu.

Connect With Us

  • Twitter
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
Social Media Directory

For the Media

Find an Expert Follow @SyracuseUNews
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • @SyracuseU
  • @SyracuseUNews
  • @SUCampus
  • Social Media Directory
  • Accessibility
  • Privacy
  • Campus Status
  • Syracuse.edu
© 2021 Syracuse University News. All Rights Reserved.